2,319
Views
9
CrossRef citations to date
0
Altmetric
Research Article

The association effect of insulin and clonazepam on oxidative stress in liver of an experimental animal model of diabetes and depression

, , , , , , , & show all
Pages 533-538 | Received 17 May 2012, Accepted 04 Nov 2012, Published online: 01 Feb 2013

References

  • Aebi H. (1984). Catalase in vitro. Methods Enzymol 105:121–6
  • Altomare E, Grattagliano I, Vendemaile G, et al. (1997). Oxidative protein damage in human diabetic eye: Evidence of a retinal participation. Eur J Clin Invest 27:141–7
  • Baynes JW. (2003). Chemical modification of proteins by lipids in diabetes. Clin Chem Lab Med 41:1159–65
  • Bonnefont-Rousselot D, Beaudeux JL, Therond P, et al. (2004). Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 62:147–57
  • Bouwman V, Adriaanse MC, Van 'T Riet E, et al. (2010). Depression, anxiety and glucose metabolism in the general Dutch population: The new Hoorn study. PLoS One 5:1–7
  • Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–20
  • Cakatay U. (2005). Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–7
  • Ceriello A, Morocutti A, Mercuri F, et al. (2000). Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170–7
  • Coskun O, Kanter M, Korkmaz A, Oter S. (2005). Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 51:117–23
  • Da Silva Haeser A, Sitta A, Barschak AG, et al. (2007). Oxidative stress parameters in diabetic rats submitted to forced swimming test: The clonazepam effect. Brain Res 1154:137–43
  • Di Naso FC, Simoes Dias A, Porawski M, Marroni NA. (2011). Exogenous superoxide dismutase: Action on liver oxidative stress in animals with streptozotocin-induced diabetes. Exp Diabetes Res 2011:754132
  • Essani NA, Mcguire GM, Manning AM, Jaeschke H. (1996). Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selection messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 156:2956–63
  • Gomez R, Barros HM. (2000). Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol Biochem Behav 66:329–35
  • Gonzalez JS, Peyrot M, Mccarl LA, et al. (2008). Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 31:2398–403
  • Hilakivi-Clarke LA, Wozniak KM, Durcan MJ, Linnoila M. (1990). Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol Behav 48:429–33
  • Katon W, Lin EH, Kroenke K. (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29:147–55
  • Kim KM, Kim YS, Jung DH, et al. (2011). Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp Cell Res 318:152–9
  • Kocic R, Pavlovic D, Kocic G. (2007). Impact of intensive insulin treatment on the development and consequences of oxidative stress in insulin-dependent diabetes mellitus. Vojnosanit Pregl 64:623–8
  • Kono Y, Fridovich I. (1982). Superoxide radical inhibits catalase. J Biol Chem 257:5751–4
  • Levine RL, Garland D, Oliver CN, et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–78
  • Lorenzi R, Andrades ME, Bortolin RC, et al. (2010). Circulating glycolaldehyde induces oxidative damage in the kidney of rats. Diabetes Res Clin Pract 89:262–7
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
  • Lustman PJ, Anderson RJ, Freedland KE, et al. (2000). Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care 23:934–42
  • Mannervik B, Aronsson AC, Marmstal E, Tibbelin G. (1981). Glyoxalase I (rat liver). Methods Enzymol 77:297–301
  • Matsumoto T, Ozawa Y, Taguchi K, et al. (2010). Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction. Peptides 31:346–53
  • Misra HP, Fridovich I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–5
  • Morishita S. (2009). Clonazepam as a therapeutic adjunct to improve the management of depression: A brief review. Hum Psychopharmacol 24:191–8
  • Pan HZ, Zhang H, Chang D, et al. (2008). The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–51
  • Porsolt RD, Le Pichon M, Jalfre M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730–2
  • Rabbani N, Thornalley PJ. (2011). Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol 22:309–17
  • Ren XY, Li YN, Qi JS, Niu T. (2008). Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J Diabetes Complications 22:357–64
  • Robles GI, Sigh-Franco D. (2009). A review of exenatide as adjuntive therapy in patients with type 2 diabetes. Drug Des Devel Ther 3:219–40
  • Sadi G, Guray T. (2009). Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: Effect of antioxidants. Mol Cell Biochem 327:127–34
  • Telci A, Cakatay U, Salman S, et al. (2000). Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 50:213–23
  • Wayhs CA, Manfredini V, Sitta A, et al. (2010a). Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: The insulin and clonazepam effect. Metab Brain Dis 25:297–304
  • Wayhs CA, Manfredini V, Sitta A, et al. (2010b). Effects of insulin and clonazepam on DNA damage in diabetic rats submitted to the forced swimming test. Mutat Res 703:187–90
  • Wiernsperger NF. (2003). Oxidative stress as a therapeutic target in diabetes: Revisiting the controversy. Diabetes Metab 29:579–85
  • Wu JC, Li XH, Peng YD, et al. (2011). Association of two glyoxalase 1 gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. J Endocrinol Invest 34:343–8
  • Yilmaz HR, Uz E, Yucel N, et al. (2004). Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18:234–8
  • Zimmet P, Alberti KG, Shaw J. (2001). Global and societal implications of the diabetes epidemic. Nature 414:782–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.